Chimeric Antigen Receptor Cell Therapy
Chimeric Antigen Receptor Cell Therapy market is segmented by region (country), players, by Type ... Read More
1 Study Coverage 1.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Introduction 1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Outlook 2017 VS 2022 VS 2028 1.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in US$ Million for the Year 2017-2028 1.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume for the Year 2017-2028 1.3 United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Outlook 2017 VS 2022 VS 2028 1.3.1 United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in US$ Million for the Year 2017-2028 1.3.2 United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume for the Year 2017-2028 1.4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Dynamics 1.5.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Trends 1.5.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Drivers 1.5.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Challenges 1.5.4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Segment by Type 2.1.1 Control Hyperphosphatemia 2.1.2 Maintain Blood Calcium Levels 2.1.3 Control PTH Level 2.1.4 Correct Acidosis 2.1.5 Other 2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Type 2.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Type 2.3.1 United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Segment by Application 3.1.1 Hospital Pharmacies 3.1.2 Retail Pharmacies 3.1.3 Online Pharmacies 3.1.4 Drug Stores 3.1.5 Other 3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Application 3.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Application 3.3.1 United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Competitor Landscape by Company 4.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Company 4.1.1 Top Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturers Ranked by Revenue (2021) 4.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Manufacturer (2017-2022) 4.1.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Manufacturer (2017-2022) 4.1.4 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Manufacturer (2017-2022) 4.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Concentration Ratio (CR) 4.2.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) in 2021 4.2.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base Distribution, Product Type 4.3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Type 4.3.3 Date of International Manufacturers Enter into Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Company 4.5.1 Top Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Players in United States, Ranked by Revenue (2021) 4.5.2 United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Players (2020, 2021 & 2022) 4.5.3 United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Players (2020, 2021 & 2022) 5 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Region 5.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size in Volume by Region (2017-2028) 5.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume by Region: 2017-2022 5.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume Forecast by Region (2023-2028) 5.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size in Value by Region (2017-2028) 5.3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value by Region: 2017-2022 5.3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size YoY Growth 2017-2028 6.1.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size YoY Growth 2017-2028 6.3.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size YoY Growth 2017-2028 6.4.2 Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Akebia 7.1.1 Akebia Corporation Information 7.1.2 Akebia Description and Business Overview 7.1.3 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2017-2022) 7.1.4 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered 7.1.5 Akebia Recent Development 7.2 Astellas 7.2.1 Astellas Corporation Information 7.2.2 Astellas Description and Business Overview 7.2.3 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2017-2022) 7.2.4 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered 7.2.5 Astellas Recent Development 7.3 Takeda 7.3.1 Takeda Corporation Information 7.3.2 Takeda Description and Business Overview 7.3.3 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2017-2022) 7.3.4 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered 7.3.5 Takeda Recent Development 7.4 Vifor 7.4.1 Vifor Corporation Information 7.4.2 Vifor Description and Business Overview 7.4.3 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2017-2022) 7.4.4 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered 7.4.5 Vifor Recent Development 7.5 Abbvie 7.5.1 Abbvie Corporation Information 7.5.2 Abbvie Description and Business Overview 7.5.3 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2017-2022) 7.5.4 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered 7.5.5 Abbvie Recent Development 7.6 Fresenius 7.6.1 Fresenius Corporation Information 7.6.2 Fresenius Description and Business Overview 7.6.3 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2017-2022) 7.6.4 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered 7.6.5 Fresenius Recent Development 7.7 Abbott 7.7.1 Abbott Corporation Information 7.7.2 Abbott Description and Business Overview 7.7.3 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2017-2022) 7.7.4 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered 7.7.5 Abbott Recent Development 7.8 Novadiol 7.8.1 Novadiol Corporation Information 7.8.2 Novadiol Description and Business Overview 7.8.3 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2017-2022) 7.8.4 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered 7.8.5 Novadiol Recent Development 7.9 Japan Tobacco Company 7.9.1 Japan Tobacco Company Corporation Information 7.9.2 Japan Tobacco Company Description and Business Overview 7.9.3 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2017-2022) 7.9.4 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered 7.9.5 Japan Tobacco Company Recent Development 7.10 Daiichi-Sankyo 7.10.1 Daiichi-Sankyo Corporation Information 7.10.2 Daiichi-Sankyo Description and Business Overview 7.10.3 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2017-2022) 7.10.4 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered 7.10.5 Daiichi-Sankyo Recent Development 7.11 Shield 7.11.1 Shield Corporation Information 7.11.2 Shield Description and Business Overview 7.11.3 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2017-2022) 7.11.4 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered 7.11.5 Shield Recent Development 7.12 Spectrum 7.12.1 Spectrum Corporation Information 7.12.2 Spectrum Description and Business Overview 7.12.3 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2017-2022) 7.12.4 Spectrum Products Offered 7.12.5 Spectrum Recent Development 7.13 OPKO 7.13.1 OPKO Corporation Information 7.13.2 OPKO Description and Business Overview 7.13.3 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2017-2022) 7.13.4 OPKO Products Offered 7.13.5 OPKO Recent Development 7.14 Ardelyx 7.14.1 Ardelyx Corporation Information 7.14.2 Ardelyx Description and Business Overview 7.14.3 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2017-2022) 7.14.4 Ardelyx Products Offered 7.14.5 Ardelyx Recent Development 7.15 Sanofi Genzyme 7.15.1 Sanofi Genzyme Corporation Information 7.15.2 Sanofi Genzyme Description and Business Overview 7.15.3 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2017-2022) 7.15.4 Sanofi Genzyme Products Offered 7.15.5 Sanofi Genzyme Recent Development 7.16 Amgen 7.16.1 Amgen Corporation Information 7.16.2 Amgen Description and Business Overview 7.16.3 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue and Gross Margin (2017-2022) 7.16.4 Amgen Products Offered 7.16.5 Amgen Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Chain Analysis 8.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Distributors 8.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production Mode & Process 8.4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales and Marketing 8.4.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Channels 8.4.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Distributors 8.5 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer
List of Tables Table 1. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Trends Table 3. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Drivers Table 4. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Challenges Table 5. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Restraints Table 6. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Share by Manufacturer, 2017-2022 Table 13. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Manufacturer, (MT), 2017-2022 Table 14. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Share by Manufacturer, 2017-2022 Table 15. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Manufacturer (2017-2022) & (USD/Kg) Table 16. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) as of 2021) Table 18. Top Players of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Type Table 20. Date of International Manufacturers Enter into Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Players in United States Market, Ranking by Revenue (2021) Table 23. United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Players, (MT), 2020, 2021 & 2022 Table 26. United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume by Region (2017-2022) & (MT) Table 29. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume Forecast by Region (2023-2028) & (MT) Table 30. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume by Country (2017-2028) & (MT) Table 33. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume by Region (2017-2028) & (MT) Table 35. Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume by Country (2017-2028) & (MT) Table 37. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume by Country (2017-2028) & (MT) Table 39. Latin Americaa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume by Country (2017-2028) & (MT) Table 41. Middle East and Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value by Country (2017-2028) & (US$ Million) Table 42. Akebia Corporation Information Table 43. Akebia Description and Business Overview Table 44. Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 45. Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Table 46. Akebia Recent Development Table 47. Astellas Corporation Information Table 48. Astellas Description and Business Overview Table 49. Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 50. Astellas Product Table 51. Astellas Recent Development Table 52. Takeda Corporation Information Table 53. Takeda Description and Business Overview Table 54. Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 55. Takeda Product Table 56. Takeda Recent Development Table 57. Vifor Corporation Information Table 58. Vifor Description and Business Overview Table 59. Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 60. Vifor Product Table 61. Vifor Recent Development Table 62. Abbvie Corporation Information Table 63. Abbvie Description and Business Overview Table 64. Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 65. Abbvie Product Table 66. Abbvie Recent Development Table 67. Fresenius Corporation Information Table 68. Fresenius Description and Business Overview Table 69. Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 70. Fresenius Product Table 71. Fresenius Recent Development Table 72. Abbott Corporation Information Table 73. Abbott Description and Business Overview Table 74. Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 75. Abbott Product Table 76. Abbott Recent Development Table 77. Novadiol Corporation Information Table 78. Novadiol Description and Business Overview Table 79. Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 80. Novadiol Product Table 81. Novadiol Recent Development Table 82. Japan Tobacco Company Corporation Information Table 83. Japan Tobacco Company Description and Business Overview Table 84. Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 85. Japan Tobacco Company Product Table 86. Japan Tobacco Company Recent Development Table 87. Daiichi-Sankyo Corporation Information Table 88. Daiichi-Sankyo Description and Business Overview Table 89. Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 90. Daiichi-Sankyo Product Table 91. Daiichi-Sankyo Recent Development Table 92. Shield Corporation Information Table 93. Shield Description and Business Overview Table 94. Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 95. Shield Product Table 96. Shield Recent Development Table 97. Spectrum Corporation Information Table 98. Spectrum Description and Business Overview Table 99. Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 100. Spectrum Product Table 101. Spectrum Recent Development Table 102. OPKO Corporation Information Table 103. OPKO Description and Business Overview Table 104. OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 105. OPKO Product Table 106. OPKO Recent Development Table 107. Ardelyx Corporation Information Table 108. Ardelyx Description and Business Overview Table 109. Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 110. Ardelyx Product Table 111. Ardelyx Recent Development Table 112. Sanofi Genzyme Corporation Information Table 113. Sanofi Genzyme Description and Business Overview Table 114. Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 115. Sanofi Genzyme Product Table 116. Sanofi Genzyme Recent Development Table 117. Amgen Corporation Information Table 118. Amgen Description and Business Overview Table 119. Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022) Table 120. Amgen Product Table 121. Amgen Recent Development Table 122. Key Raw Materials Lists Table 123. Raw Materials Key Suppliers Lists Table 124. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Customers List Table 125. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Distributors List Table 126. Research Programs/Design for This Report Table 127. Key Data Information from Secondary Sources Table 128. Key Data Information from Primary Sources List of Figures Figure 1. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Picture Figure 2. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size 2017-2028 (US$ Million) Figure 4. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales 2017-2028 (MT) Figure 5. United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size 2017-2028 (US$ Million) Figure 7. United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales 2017-2028 (MT) Figure 8. United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share in Global, in Volume (MT) 2017-2028 Figure 10. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Report Years Considered Figure 11. Product Picture of Control Hyperphosphatemia Figure 12. Product Picture of Maintain Blood Calcium Levels Figure 13. Product Picture of Control PTH Level Figure 14. Product Picture of Correct Acidosis Figure 15. Product Picture of Other Figure 16. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Type in 2022 & 2028 Figure 17. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value by Type (2017-2028) & (US$ Million) Figure 18. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Value by Type (2017-2028) Figure 19. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2017-2028) & (MT) Figure 20. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Volume by Type (2017-2028) Figure 21. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Type (2017-2028) & (USD/Kg) Figure 22. United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Type in 2022 & 2028 Figure 23. United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value by Type (2017-2028) & (US$ Million) Figure 24. United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Value by Type (2017-2028) Figure 25. United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2017-2028) & (MT) Figure 26. United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Volume by Type (2017-2028) Figure 27. United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Type (2017-2028) & (USD/Kg) Figure 28. Product Picture of Hospital Pharmacies Figure 29. Product Picture of Retail Pharmacies Figure 30. Product Picture of Online Pharmacies Figure 31. Product Picture of Drug Stores Figure 32. Product Picture of Other Figure 33. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Application in 2022 & 2028 Figure 34. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value by Application (2017-2028) & (US$ Million) Figure 35. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Value by Application (2017-2028) Figure 36. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2017-2028) & (MT) Figure 37. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Volume by Application (2017-2028) Figure 38. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Application (2017-2028) & (USD/Kg) Figure 39. United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Share by Application in 2022 & 2028 Figure 40. United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value by Application (2017-2028) & (US$ Million) Figure 41. United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Value by Application (2017-2028) Figure 42. United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2017-2028) & (MT) Figure 43. United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share in Volume by Application (2017-2028) Figure 44. United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Application (2017-2028) & (USD/Kg) Figure 45. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume Growth Rate 2017-2028 (MT) Figure 46. North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 47. U.S. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 48. Canada Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume Growth Rate 2017-2028 (MT) Figure 50. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 51. Germany Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 52. France Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 53. U.K. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 54. Italy Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 55. Russia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume Growth Rate 2017-2028 (MT) Figure 57. Asia-Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 58. China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. South Korea Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Australia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 63. Taiwan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 64. Indonesia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 65. Thailand Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 66. Malaysia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 67. Philippines Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 68. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume Growth Rate 2017-2028 (MT) Figure 69. Latin America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 70. Mexico Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 71. Brazil Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 72. Argentina Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 73. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Volume Growth Rate 2017-2028 (MT) Figure 74. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 75. Turkey Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 76. Saudi Arabia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 77. U.A.E Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 78. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Value Chain Figure 79. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production Process Figure 80. Channels of Distribution Figure 81. Distributors Profiles Figure 82. Bottom-up and Top-down Approaches for This Report Figure 83. Data Triangulation Figure 84. Key Executives Interviewed
Akebia Astellas Takeda Vifor Abbvie Fresenius Abbott Novadiol Japan Tobacco Company Daiichi-Sankyo Shield Spectrum OPKO Ardelyx Sanofi Genzyme Amgen
Chimeric Antigen Receptor Cell Therapy market is segmented by region (country), players, by Type ... Read More
Adoptive Cellular Immunotherapy market is segmented by region (country), players, by Type and by ... Read More
XYZ Color Sensors market is segmented by region (country), players, by Type and by Application. P ... Read More
CoolSculpting/Zeltiq market is segmented by region (country), players, by Type and by Application ... Read More